Bladder preservation based on trimodal therapy (TMT) is an option for muscle-invasive bladder cancer (MIBC) patients unwilling to undergo radical cystectomy (RC) or unfit for radical surgery. Although randomized studies are missing, numerous reprospective and prospective series showed that TMT offers satisfactory oncological outcomes, comparable to RC with or without chemotherapy, with salvage cystectomy being reserved for patients with incomplete response or local muscle-invasive relapse. Regarding the irradiation, the standard fractionation usually is of 1.8-2 Gy/fraction with the total irradiation dose to the whole bladder being approximately 55-66 Gy and 45-50 Gy to the pelvic lymph nodes. The recent advances in the radiotherapic field, such as the introduction of intensity modulated radiotherapy (IMRT) and the image guided radiotherapy (IGRT), have improved conformity of the radiation dose to the target volume and reduced the gastrointestinal and genitourinary toxicity. Based on the current literature TMT option should be discussed in highly selected patients motivated to preserve their urinary bladder.
Radiotherapy for the treatment of muscle-invasive bladder cancer / B.A. Jereczek-Fossa, G. Marvaso - In: Treating Urothelial Bladder Cancer / [a cura di] F. Soria, P. Gontero. - [s.l] : Springer International Publishing, 2018. - ISBN 9783319785585. - pp. 83-89
Radiotherapy for the treatment of muscle-invasive bladder cancer
B.A. Jereczek-Fossa;G. Marvaso
2018
Abstract
Bladder preservation based on trimodal therapy (TMT) is an option for muscle-invasive bladder cancer (MIBC) patients unwilling to undergo radical cystectomy (RC) or unfit for radical surgery. Although randomized studies are missing, numerous reprospective and prospective series showed that TMT offers satisfactory oncological outcomes, comparable to RC with or without chemotherapy, with salvage cystectomy being reserved for patients with incomplete response or local muscle-invasive relapse. Regarding the irradiation, the standard fractionation usually is of 1.8-2 Gy/fraction with the total irradiation dose to the whole bladder being approximately 55-66 Gy and 45-50 Gy to the pelvic lymph nodes. The recent advances in the radiotherapic field, such as the introduction of intensity modulated radiotherapy (IMRT) and the image guided radiotherapy (IGRT), have improved conformity of the radiation dose to the target volume and reduced the gastrointestinal and genitourinary toxicity. Based on the current literature TMT option should be discussed in highly selected patients motivated to preserve their urinary bladder.File | Dimensione | Formato | |
---|---|---|---|
Jereczek-Fossa-Marvaso2018_Chapter_RadiotherapyForTheTreatmentOfM.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
277.2 kB
Formato
Adobe PDF
|
277.2 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.